Literature DB >> 14630624

Beta2-microglobulin knockout mice treated with anti-asialoGM1 exhibit improved hemodynamics and cardiac contractile function during acute intra-abdominal sepsis.

Weike Tao1, Edward R Sherwood.   

Abstract

We previously showed that beta2-microglobulin knockout mice treated with anti-asialoGM1 (beta2M/alphaAsGM1 mice) exhibit less hypothermia, reduced production of proinflammatory cytokines, less metabolic acidosis, and improved survival after cecal ligation and puncture (CLP) compared with wild-type mice. The present study was designed to assess hemodynamics and left ventricular contractility at 18 h after CLP. Arterial pressure was measured by carotid artery cannulation, and left ventricular pressure-volume loops were obtained by insertion of a 1.4-F conductance catheter into the left ventricle. Heart rate, stroke volume, and cardiac output were not significantly different between wild-type and beta2M/alphaAsGM1 mice after CLP. However, beta2M/alphaAsGM1 mice exhibited improved mean arterial pressure and systemic vascular resistance compared with wild-type mice. Myocardial function was also better preserved in beta2M/alphaAsGM1 mice as indicated by improved left ventricular pressure development over time, time-varying maximum elastance, endsystolic pressure-volume relationship, and preload recruitable stroke work. Overall, this study shows that cardiovascular collapse characterized by hypotension, myocardial depression, and low systemic vascular resistance occurs after CLP in wild-type mice. However, beta2M/alphaAsGM1 mice exhibit improved hemodynamics and cardiac contractile function after CLP that may account, in part, for our previously observed survival benefit.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630624     DOI: 10.1152/ajpregu.00470.2003

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

1.  NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis.

Authors:  Anthony O Etogo; Jesus Nunez; Cheng Y Lin; Tracy E Toliver-Kinsky; Edward R Sherwood
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

2.  Use of pressure-volume conductance catheters in real-time cardiovascular experimentation.

Authors:  Abraham E Wei; Mikhail Y Maslov; Matthew J Pezone; Elazer R Edelman; Mark A Lovich
Journal:  Heart Lung Circ       Date:  2014-05-22       Impact factor: 2.975

3.  Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.

Authors:  Yongli Kong; Paul Tannous; Guangrong Lu; Kambeez Berenji; Beverly A Rothermel; Eric N Olson; Joseph A Hill
Journal:  Circulation       Date:  2006-05-30       Impact factor: 29.690

4.  Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock.

Authors:  Daniela S Herzig; Brandon R Driver; Geping Fang; Tracy E Toliver-Kinsky; Eric N Shute; Edward R Sherwood
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

Review 5.  The biology of natural killer cells during sepsis.

Authors:  Yin Guo; Naeem K Patil; Liming Luan; Julia K Bohannon; Edward R Sherwood
Journal:  Immunology       Date:  2017-11-16       Impact factor: 7.397

6.  Age-dependent differences of interleukin-6 activity in cardiac function after burn complicated by sepsis.

Authors:  Lin Wang; Jiexia Quan; William E Johnston; David L Maass; Jureta W Horton; James A Thomas; Weike Tao
Journal:  Burns       Date:  2009-06-06       Impact factor: 2.744

7.  Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.

Authors:  Isaac J Jensen; Christina S Winborn; Micaela G Fosdick; Peng Shao; Mikaela M Tremblay; Qiang Shan; Sandeep Kumar Tripathy; Christopher M Snyder; Hai-Hui Xue; Thomas S Griffith; Jon C Houtman; Vladimir P Badovinac
Journal:  PLoS Pathog       Date:  2018-10-31       Impact factor: 6.823

Review 8.  Immune Intervention in Sepsis.

Authors:  Jian Chen; Haiming Wei
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.